Treatment Trials

1 Clinical Trials for Various Conditions

Focus your search

      COMPLETED
      Dose Escalation Study of ARQ 621 in Adult Patients With Metastatic Solid Tumors and Hematologic Malignancies
      Description

      This is an open-label, dose escalation study of intravenous ARQ 621 administered to patients with late-stage solid tumors or hematologic malignancies.

      Conditions
      Metastatic Solid Tumors, Refractory/Relapsed Hematologic Malignancies
      Talk to us